Subsequently, we performed COX regression analysis on variables such as sex, age, tumor location, differentiated degree, TNM stage, and TRIM24 expression, and found that M stage and high TRIM24 expression were both independent adverse prognostic factors for GC patients (Table 2). This evidence concerns the gene TRIM24 and gastric cancer.